Gwynfor Owen Humphreys
Plus aucun poste en cours
Historique de carrière de Gwynfor Owen Humphreys
Anciens postes connus de Gwynfor Owen Humphreys
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVACTA GROUP PLC | Directeur/Membre du Conseil | 13/07/2006 | 23/01/2015 |
| Président | 24/12/2010 | 24/01/2014 | |
| GUNSYND PLC | Directeur/Membre du Conseil | 01/10/2004 | 15/09/2014 |
| Directeur Général | 03/05/2012 | 15/09/2014 | |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Fondateur | 01/12/1995 | 01/01/2001 |
| President | 01/12/1995 | 01/01/2001 | |
SolAeroMed, Inc.
 SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Royaume-Uni | 4 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| GUNSYND PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SolAeroMed, Inc.
SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
- Bourse
- Insiders
- Gwynfor Owen Humphreys
- Expérience
